Literature DB >> 22551651

The feasibility of 350 μm spatial resolution coronary magnetic resonance angiography at 3 T in humans.

Ahmed M Gharib1, Khaled Z Abd-Elmoniem, Vincent B Ho, Eszter Födi, Daniel A Herzka, Jacques Ohayon, Matthias Stuber, Roderic I Pettigrew.   

Abstract

PURPOSE: The purposes of this study were to (1) develop a high-resolution 3-T magnetic resonance angiography (MRA) technique with an in-plane resolution approximate to that of multidetector coronary computed tomography (MDCT) and a voxel size of 0.35 × 0.35 × 1.5 mm³ and to (2) investigate the image quality of this technique in healthy participants and preliminarily in patients with known coronary artery disease (CAD).
MATERIALS AND METHODS: A 3-T coronary MRA technique optimized for an image acquisition voxel as small as 0.35 × 0.35 × 1.5 mm³ (high-resolution coronary MRA [HRC]) was implemented and the coronary arteries of 22 participants were imaged. These included 11 healthy participants (average age, 28.5 years; 5 men) and 11 participants with CAD (average age, 52.9 years; 5 women) as identified on MDCT. In addition, the 11 healthy participants were imaged using a method with a more common spatial resolution of 0.7 × 1 × 3 mm³ (regular-resolution coronary MRA [RRC]). Qualitative and quantitative comparisons were made between the 2 MRA techniques.
RESULTS: Normal vessels and CAD lesions were successfully depicted at 350 × 350 μm² in-plane resolution with adequate signal-to-noise ratio (SNR) and contrast-to-noise ratio. The CAD findings were consistent among MDCT and HRC. The HRC showed a 47% improvement in sharpness despite a reduction in SNR (by 72%) and in contrast-to-noise ratio (by 86%) compared with the regular-resolution coronary MRA.
CONCLUSION: This study, as a first step toward substantial improvement in the resolution of coronary MRA, demonstrates the feasibility of obtaining at 3 T a spatial resolution that approximates that of MDCT. The acquisition in-plane pixel dimensions are as small as 350 × 350 μm² with a 1.5-mm slice thickness. Although SNR is lower, the images have improved sharpness, resulting in image quality that allows qualitative identification of disease sites on MRA consistent with MDCT.

Entities:  

Mesh:

Year:  2012        PMID: 22551651      PMCID: PMC3349009          DOI: 10.1097/RLI.0b013e3182479ec4

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  29 in total

1.  Double-oblique free-breathing high resolution three-dimensional coronary magnetic resonance angiography.

Authors:  M Stuber; R M Botnar; P G Danias; D K Sodickson; K V Kissinger; M Van Cauteren; J De Becker; W J Manning
Journal:  J Am Coll Cardiol       Date:  1999-08       Impact factor: 24.094

2.  Submillimeter three-dimensional coronary MR angiography with real-time navigator correction: comparison of navigator locations.

Authors:  M Stuber; R M Botnar; P G Danias; K V Kissinger; W J Manning
Journal:  Radiology       Date:  1999-08       Impact factor: 11.105

3.  Whole-heart coronary magnetic resonance angiography at 1.5 Tesla: does a blood-pool contrast agent improve diagnostic accuracy?

Authors:  Moritz Wagner; Roberta Rösler; Alexander Lembcke; Craig Butler; Marc Dewey; Michael Laule; Alexander Huppertz; Carsten Schwenke; Carsten Warmuth; Matthias Rief; Bernd Hamm; Matthias Taupitz
Journal:  Invest Radiol       Date:  2011-03       Impact factor: 6.016

4.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

Authors:  W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

Review 5.  Computed tomography coronary angiography.

Authors:  Stephan Achenbach
Journal:  J Am Coll Cardiol       Date:  2006-11-01       Impact factor: 24.094

6.  Contrast-enhanced coronary artery visualization by dual-source computed tomography--initial experience.

Authors:  Stephan Achenbach; Dieter Ropers; Axel Kuettner; Thomas Flohr; Bernd Ohnesorge; Herbert Bruder; Heike Theessen; Meri Karakaya; Werner G Daniel; Werner Bautz; Willi A Kalender; Katharina Anders
Journal:  Eur J Radiol       Date:  2006-01-19       Impact factor: 3.528

7.  Coronary magnetic resonance angiography for the detection of coronary stenoses.

Authors:  W Y Kim; P G Danias; M Stuber; S D Flamm; S Plein; E Nagel; S E Langerak; O M Weber; E M Pedersen; M Schmidt; R M Botnar; W J Manning
Journal:  N Engl J Med       Date:  2001-12-27       Impact factor: 91.245

8.  Coronary angiography with magnetization-prepared T2 contrast.

Authors:  J H Brittain; B S Hu; G A Wright; C H Meyer; A Macovski; D G Nishimura
Journal:  Magn Reson Med       Date:  1995-05       Impact factor: 4.668

9.  Comparison of respiratory suppression methods and navigator locations for MR coronary angiography.

Authors:  M V McConnell; V C Khasgiwala; B J Savord; M H Chen; M L Chuang; R R Edelman; W J Manning
Journal:  AJR Am J Roentgenol       Date:  1997-05       Impact factor: 3.959

10.  Preliminary report on in vivo coronary MRA at 3 Tesla in humans.

Authors:  Matthias Stuber; René M Botnar; Stefan E Fischer; Rolf Lamerichs; Jouke Smink; Paul Harvey; Warren J Manning
Journal:  Magn Reson Med       Date:  2002-09       Impact factor: 4.668

View more
  9 in total

1.  High-resolution variable-density 3D cones coronary MRA.

Authors:  Nii Okai Addy; R Reeve Ingle; Holden H Wu; Bob S Hu; Dwight G Nishimura
Journal:  Magn Reson Med       Date:  2015-07-14       Impact factor: 4.668

2.  Personalized Statin Therapy and Coronary Atherosclerotic Plaque Burden in Asymptomatic Low/Intermediate-Risk Individuals.

Authors:  Ranganath Muniyappa; Radwa A Noureldin; Khaled Z Abd-Elmoniem; Riham H El Khouli; Jatin Raj Matta; Ahmed Hamimi; Siri Ranganath; Colleen Hadigan; Lynnette K Nieman; Ahmed M Gharib
Journal:  Cardiorenal Med       Date:  2018-03-26       Impact factor: 2.041

3.  Automated patient-specific optimization of three-dimensional double-inversion recovery magnetic resonance imaging.

Authors:  Refaat E Gabr; Xiaojun Sun; Amol S Pednekar; Ponnada A Narayana
Journal:  Magn Reson Med       Date:  2015-03-11       Impact factor: 4.668

4.  Accelerated isotropic sub-millimeter whole-heart coronary MRI: compressed sensing versus parallel imaging.

Authors:  Mehmet Akçakaya; Tamer A Basha; Raymond H Chan; Warren J Manning; Reza Nezafat
Journal:  Magn Reson Med       Date:  2014-02       Impact factor: 4.668

Review 5.  Prediction of cardiovascular outcomes by imaging coronary atherosclerosis.

Authors:  Faraz Pathan; Kazuaki Negishi
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

6.  Feasibility of coronary artery wall thickening assessment in asymptomatic coronary artery disease using phase-sensitive dual-inversion recovery MRI at 3T.

Authors:  Ahmed M Gharib; Homeira Zahiri; Jatin Matta; Roderic I Pettigrew; Khaled Z Abd-Elmoniem
Journal:  Magn Reson Imaging       Date:  2013-05-01       Impact factor: 2.546

7.  3.0-T whole-heart coronary magnetic resonance angiography: comparison of gadobenate dimeglumine and gadofosveset trisodium.

Authors:  Fabio S Raman; Marcelo S Nacif; George Cater; Neville Gai; Jacquin Jones; Debiao Li; Christopher T Sibley; Songtao Liu; David A Bluemke
Journal:  Int J Cardiovasc Imaging       Date:  2013-03-21       Impact factor: 2.357

8.  Automatic Coronary Wall and Atherosclerotic Plaque Segmentation from 3D Coronary CT Angiography.

Authors:  Ahmed M Ghanem; Ahmed H Hamimi; Jatin R Matta; Aaron Carass; Reham M Elgarf; Ahmed M Gharib; Khaled Z Abd-Elmoniem
Journal:  Sci Rep       Date:  2019-01-10       Impact factor: 4.379

9.  Five-minute whole-heart coronary MRA with sub-millimeter isotropic resolution, 100% respiratory scan efficiency, and 3D-PROST reconstruction.

Authors:  Aurélien Bustin; Giulia Ginami; Gastão Cruz; Teresa Correia; Tevfik F Ismail; Imran Rashid; Radhouene Neji; René M Botnar; Claudia Prieto
Journal:  Magn Reson Med       Date:  2018-07-29       Impact factor: 4.668

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.